Complement-ARIE New Approach Methodologies (NAMs) Technology Development Centers (UM1 Clinical Trial Optional)

Due: Mar 18, 2025

Description

The purpose of this Notice of Funding Opportunity (NOFO) is to establish Comprehensive NAMs Technology Development Centers to support NIH Common Funds Complement Animal Research In Experimentation (Complement-ARIE) program. The Complement-ARIE program will accelerate the development, standardization, validation, and use of human-based New Approach Methodologies (NAMs). Complement-ARIE will significantly advance understanding of human health and disease by providing a range of mature and/or validated and standardized biomedical re...

Eligible Applicants- State governments- County governments- City or township governments- Special district governments- Independent school districts- Public and State controlled institutions of higher education- Native American tribal governments (Federally recognized)- Public housing authorities/Indian housing authorities- Native American tribal organizations (other than Federally recognized tribal governments)- Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education- Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education- Private institutions of higher education- For-profit organizations other than small businesses- Small businesses- Others

Additional Eligibility Information

Other Eligible Applicants include the following:Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Cont...

Funding TypeCooperative AgreementCategories of Funding Activity- HealthOpportunity TypeDiscretionary

Grantor Contact InformationSee Section VII. Agency Contacts within the full opportunity announcement for all other inquires.Grantor Emailgrantsinfo@nih.govOther Grantor InformationNIH Grants Information <br/>grantsinfo@nih.gov

Additional Informationhttps://grants.nih.gov/grants/guide/rfa-files/RFA-RM-24-010.htmlSupporting Linkhttp://grants.nih.gov/grants/guide/rfa-files/RFA-RM-24-010.html

Start finding grants with Atom for

$0 today

$30 Billed monthly after 7-day trial. Cancel anytime.

Personalized grant emails delivered weekly, right to your inbox.

AI powered search engine with both keyword and semantic search capabilities.

Grant filters to find the perfect funding opportunities.

Similar Grants

Eligibility

Profile

Finance

Other

Similar Grants

Complement-ARIE New Approach Methodologies (NAMs) Technology Development Centers (UM1 Clinical Trial Optional)

Start finding grants with Atom for

$0 today

$30 Billed monthly after 7-day trial. Cancel anytime.

Personalized grant emails delivered weekly, right to your inbox.

AI powered search engine with both keyword and semantic search capabilities.

Grant filters to find the perfect funding opportunities.

Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)

Complement-ARIE New Approach Methodologies (NAMs) Technology Development Centers (UM1 Clinical Trial Optional)

Start finding grants with Atom for

$0 today

$30 Billed monthly after 7-day trial. Cancel anytime.

Personalized grant emails delivered weekly, right to your inbox.

AI powered search engine with both keyword and semantic search capabilities.

Grant filters to find the perfect funding opportunities.

Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)